1. Griciuc, Ana, Federico, Anthony N, Natasan, Jeyashree, Tanzi, Rudolph E, Maguire, Casey A. . Gene therapy for Alzheimer's disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation. In Human molecular genetics, 29, 2920-2935. doi:10.1093/hmg/ddaa179. https://pubmed.ncbi.nlm.nih.gov/32803224/
2. Kim, Miriam Y, Yu, Kyung-Rok, Kenderian, Saad S, Dunbar, Cynthia E, Gill, Saar. 2018. Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia. In Cell, 173, 1439-1453.e19. doi:10.1016/j.cell.2018.05.013. https://pubmed.ncbi.nlm.nih.gov/29856956/
3. Toor, Salman M, Taha, Rowaida Z, Sasidharan Nair, Varun, Abu Nada, Mohamed, Elkord, Eyad. 2020. Differential gene expression of tumor-infiltrating CD33+ myeloid cells in advanced- versus early-stage colorectal cancer. In Cancer immunology, immunotherapy : CII, 70, 803-815. doi:10.1007/s00262-020-02727-0. https://pubmed.ncbi.nlm.nih.gov/33000418/
4. Silva, Harrison J, Martin, Grace, Birocchi, Filippo, Maus, Marcela V, Leick, Mark B. . CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML. In Blood, 145, 720-731. doi:10.1182/blood.2023023210. https://pubmed.ncbi.nlm.nih.gov/39571145/
5. Mehdizadeh, Elham, Khalaj-Kondori, Mohammad, Shaghaghi-Tarakdari, Zeinab, Talebi, Mahnaz, Andalib, Sasan. 2019. Association of MS4A6A, CD33, and TREM2 gene polymorphisms with the late-onset Alzheimer's disease. In BioImpacts : BI, 9, 219-225. doi:10.15171/bi.2019.27. https://pubmed.ncbi.nlm.nih.gov/31799158/
6. Bexte, Tobias, Albinger, Nawid, Al Ajami, Ahmad, Imkeller, Katharina, Ullrich, Evelyn. 2024. CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells. In Nature communications, 15, 8439. doi:10.1038/s41467-024-52388-1. https://pubmed.ncbi.nlm.nih.gov/39349459/
7. Borot, Florence, Humbert, Olivier, Newby, Gregory A, Mukherjee, Siddhartha, Kiem, Hans-Peter. 2023. Multiplex Base Editing to Protect from CD33-Directed Therapy: Implications for Immune and Gene Therapy. In bioRxiv : the preprint server for biology, , . doi:10.1101/2023.02.23.529353. https://pubmed.ncbi.nlm.nih.gov/36865281/
智鼠故事 
